Publicly Traded and Startup Cannabis Financial News for the Week Ending July 22nd, 2022

July 18th

Red White & Bloom Brands (CSE: RWB)(OTC: RWBYF) Missed Audit Target.
 
MedMen (OTC: MMNFF) Was Sued For Almost $1 Million In Back Rent.

Clever Leaves Holdings Inc. (NASDAQ: CLVR, CLVRW) announced the first commercial export to Israel of high THC Flower for medical use.

Small Pharma Inc. (TSXV: DMT) (OTCQB: DMTTF), published its financial results for the quarter ended May 31, 2022.

July 19th
 
Cannabis firm Alleaves raises $40 million for multi-state roll-out of seed-to-sale technology.

High Tide Inc. (NASDAQ: HITI) (TSXV: HITI) entered an agreement with Echelon Wealth Partners Inc.

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) announced closure of its previously announced exchange transaction of certain 4.25% unsecured notes due 2023.

Juva Life Inc. (CSE: JUVA) (OTCQB: JUVAF) announced its financial and operating results for Q1 of 2022, with $1.16 million of revenue in Q1 2022

ZYUS Life Sciences Inc. has completed its first international shipment of ZYUS’ first-generation cannabinoid oil formulations to the Australian medical cannabis market.

July 20th
 
Pink Market Capital Research examined how Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) has managed to rake in more revenue during the past year than its competitors.

Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) entered into an intellectual property licensing & royalty agreement with Ei.Ventures, Inc.

Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) launched Heritage Helps, a new program that combines initiatives that support the environment and communities in which it operates.

July 21st
 
Zelira Therapeutics (ASX: ZLD,OTC-QB: ZLDAF) announced that its insomnia medication Zenivol™ achieved formal approval from German regulatory authority BfArM.

Delic Holdings Corp (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) reported revenue in excess of USD$1.5MM and increased net assets from USD$2.1MM in 2020 to USD$10MM.

Zynerba Pharmaceuticals (Nasdaq: ZYNE) seals $20 million equity deal with a capital fund.

Metrc reaches an agreement with Rhode Island for medical cannabis regulation.

Comments

Popular posts from this blog

Publicly Traded and Startup Cannabis Financial News for the Week Ending August 1st, 2022

Publicly Traded and Startup Cannabis Financial News for the Week Ending August 8th, 2022